We are live on
!
Find out more
HSA
Hussman Strategic Advisors Portfolio holdings
AUM
$434M
1-Year Est. Return
19.64%
This Fund
S&P 500
This Quarter
Est. Return
+8.02%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$434M
AUM Growth
-$28.5M
(-6.2%)
Cap. Flow
-$39M
Cap. Flow
% of AUM
-8.97%
Top 10 Holdings %
Top 10 Hldgs %
10.4%
Holding
334
New
66
Increased
40
Reduced
42
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$4.08M |
| 2 |
Ubiquiti
UI
|
+$3.96M |
| 3 |
Salesforce
CRM
|
+$3.69M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$3.57M |
| 5 |
Globus Medical
GMED
|
+$3.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$5.08M |
| 2 |
SEZL
Sezzle
SEZL
|
+$3.99M |
| 3 |
PSIX
Power Solutions International
PSIX
|
+$3.84M |
| 4 |
Qualys
QLYS
|
+$3.69M |
| 5 |
Progyny
PGNY
|
+$3.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.08% |
| 2 | Technology | 17.18% |
| 3 | Consumer Discretionary | 15.3% |
| 4 | Financials | 9.77% |
| 5 | Consumer Staples | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Copa Holdings
CPA
$5.32B
| – | – |
-10,500
| Closed | -$1.19M |
|
|
CPRX
252
DELISTED
Catalyst Pharmaceutical
CPRX
| – | – |
-84,000
| Closed | -$2.08M |
|
253
Credo Technology Group
CRDO
$31.1B
| – | – |
-21,000
| Closed | -$1.97M |
|
254
Canadian Solar
CSIQ
$800M
| – | – |
-168,000
| Closed | -$2.33M |
|
|
CTRA
255
DELISTED
Coterra Energy
CTRA
| – | – |
-42,000
| Closed | -$1.48M |
|
256
Dropbox
DBX
$8.21B
| – | – |
-42,000
| Closed | -$954K |
|
|
DHC
257
Diversified Healthcare Trust
DHC
$1.95B
| – | – |
-105,000
| Closed | -$697K |
|
258
Doximity
DOCS
$4.65B
| – | – |
-21,000
| Closed | -$489K |
|
259
Dole
DOLE
$1.24B
| – | – |
-147,000
| Closed | -$2.1M |
|
260
Duolingo
DUOL
$6.85B
| – | – |
-10,500
| Closed | -$1.03M |
|
261
DexCom
DXCM
$33B
| – | – |
-10,500
| Closed | -$659K |
|
262
e.l.f. Beauty
ELF
$5.41B
| – | – |
-10,500
| Closed | -$636K |
|
263
National Vision
EYE
$1.31B
| – | – |
-105,000
| Closed | -$2.72M |
|
|
DMC
264
Del Monte Corp
DMC
$1.48B
| – | – |
-42,000
| Closed | -$1.69M |
|
265
Flowers Foods
FLO
$1.31B
| – | – |
-168,000
| Closed | -$1.37M |
|
266
Flywire
FLYW
$2.17B
| – | – |
-210,000
| Closed | -$2.44M |
|
267
Gilead Sciences
GILD
$184B
| – | – |
-10,500
| Closed | -$1.46M |
|
268
Monte Rosa Therapeutics
GLUE
$1.1B
| – | – |
-63,000
| Closed | -$1.04M |
|
269
Garrett Motion
GTX
$4.96B
| – | – |
-84,000
| Closed | -$1.53M |
|
270
Haemonetics
HAE
$4.97B
| – | – |
-10,500
| Closed | -$592K |
|
271
Hilton Grand Vacations
HGV
$2.88B
| – | – |
-21,000
| Closed | -$822K |
|
272
Herbalife
HLF
$1.27B
| – | – |
-63,000
| Closed | -$927K |
|
273
Harley-Davidson
HOG
$2.75B
| – | – |
-63,000
| Closed | -$1.27M |
|
274
Harmony Biosciences
HRMY
$2.48B
| – | – |
-84,000
| Closed | -$2.35M |
|
275
Hertz
HTZ
$677M
| – | – |
-315,000
| Closed | -$1.45M |
|
Similar funds
NICM
DCM
SCP
NRC
CEI
CFG
CAAM
OCPWS
Hussman Strategic Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Hussman Strategic Advisors held 334 positions worth $434M, down 6.2% from $463M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Hussman Strategic Advisors withdrew a net $39M in Q2 2026, closing 103 positions and reducing 42 holdings. Its most notable exit was Corcept Therapeutics, an estimated $5.08M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Hussman Strategic Advisors opened a new position in Salesforce worth $3.29M.
- Hussman Strategic Advisors's largest Q2 2026 buy was Salesforce: 21,000 shares worth $3.29M.
- Hussman Strategic Advisors added most to PepsiCo in Q2 2026, an estimated $4.08M increase.
- Hussman Strategic Advisors's biggest Q2 2026 reduction was Concentrix, cutting an estimated $2.74M.
- Hussman Strategic Advisors fully exited Corcept Therapeutics in Q2 2026, selling an estimated $5.08M.
- Hussman Strategic Advisors's ten largest holdings make up 10% of its $434M portfolio in Q2 2026.
- Hussman Strategic Advisors opened 66 new positions and closed 103 in Q2 2026.
- Hussman Strategic Advisors's portfolio value fell 6.2% quarter-over-quarter to $434M.
Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.